(Novavax) Shares of Novavax Inc. rose more than 5% in premarket on Thursday after preliminary findings showed that its Covid-19 vaccine produced strong immune responses against the Omicron. Novavax says…
(Novavax) Biotech firm Novavax announced $298 million in revenues in the second quarter ending June 30, up from 35.54 million reported in the comparable quarter of 2020. For the six…
(CNBC) Phase 3 clinical trials of Novavax vaccine trials on a sample of 29,960 participants have confirmed it is safe and 90.4% effective. Two-dose vaccine of Novavax was determined to…